Results 21 to 30 of about 294,878 (304)

Evaluating COVID-19 Booster Vaccination Strategies in a Partially Vaccinated Population: A Modeling Study

open access: yesVaccines, 2022
Background: Several countries are implementing COVID-19 booster vaccination campaigns. The objective of this study was to model the impact of different primary and booster vaccination strategies.
Clément R. Massonnaud   +3 more
doaj   +1 more source

COVID Arm After Moderna Booster in Healthcare Worker: A Case Report

open access: yesActa Medica Indonesiana, 2021
SARS CoV-2 virus has infected more than 200 million people worldwide and more than 4.4 million in Indonesia. The vaccination program has become one of the solutions launched by many countries globally, including Indonesia, to reduce the transmission rate
Anshari Saifuddin   +5 more
doaj  

Humoral and Cellular Responses to BNT162b2 as a Booster Following Two Doses of ChAdOx1 nCov-19 Determined Using Three SARS-CoV-2 Antibody Assays and an Interferon-Gamma Release Assay: A Prospective Longitudinal Study in Healthcare Workers

open access: yesFrontiers in Immunology, 2022
Data on humoral and cellular responses to BNT162b2 as a booster dose, following two doses of ChAdOx1 nCov-19 vaccine, have seldom been reported. The aim of this study was to assess the positivity rates of three representative antibody assays targeting ...
Seri Jeong   +7 more
doaj   +1 more source

Improvements in CO2 Booster Architectures with Different Economizer Arrangements. [PDF]

open access: yes, 2020
CO2 transcritical booster architectures are widely analyzed to be applied in centralized commercial refrigeration plants in consonance with the irrevocable phase-out of HFCs.
Cabello López, Ramón   +5 more
core   +1 more source

Article Hedges vs boosters: Communicative mitigation and enhancement in the genre of dissertation review [PDF]

open access: yesЖанры речи, 2023
The article presents the results of the cross-disciplinary research which focuses on the two types of discourse markers – hedges and boosters and their use in Russian official dissertation reviews.
Viktorova, Elena Yurievna
doaj   +1 more source

Homologous or heterogenous vaccination boosters enhance neutralizing activities against SARS‐CoV‐2 Omicron BA.1 variant

open access: yesMedComm, 2022
The SARS‐CoV‐2 Omicron BA.1 variant of concern contains more than 30 mutations in the spike protein, with half of these mutations localized in the receptor‐binding domain (RBD).
Zhongcheng Zhou   +17 more
doaj   +1 more source

COVID-19 Booster Vaccine Hesitancy among Hemodialysis Patients in Saudi Arabia Using the Health Belief Model: A Multi-Centre Experience

open access: yesVaccines, 2022
Objective: Vaccination hesitance for the COVID-19 booster dosage among hemodialysis patients is an important barrier in reducing morbidity and mortality linked to COVID-19 infection. Hence, this study aimed to explore the predictors of the third (booster)
Sami Alobaidi   +6 more
doaj   +1 more source

A randomised controlled trial and cost-effectiveness evaluation of 'booster' interventions to sustain increases in physical activity in middle-aged adults in deprived urban neighbourhoods [PDF]

open access: yes, 2014
Background: More evidence is needed on the potential role of 'booster' interventions in the maintenance of increases in physical activity levels after a brief intervention in relatively sedentary populations.
Breckon, Jeff   +19 more
core   +2 more sources

Insights from Team Clinic: A Person-Centered Virtual Peer Group Care Model Adapted for Marginalized and Historically Excluded Youth with Type 1 Diabetes (T1D)

open access: yesChildren
Background: Despite advancements in T1D care regimens, racially and ethnically diverse youth with low income continue to experience worse health outcomes, more psychosocial challenges, and higher barriers to care.
Jaquelin Flores Garcia   +8 more
doaj   +1 more source

Friend or foe—The Pfizer‐BioNTech (BNT162b2) vaccination: A case report of reversible acute acalculous cholecystitis

open access: yesClinical Case Reports, 2022
We described a rare case of vaccine‐induced acalculous cholecystitis (ACC). A 52‐year‐old female developed ACC after 8 h of receiving a 3rd dose of the Pfizer‐BioNTech COVID‐19 vaccination. The symptoms subsided completely with conservative treatment for
Bianca Maria Wahlen   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy